IGM Biosciences, Inc. (IGMS)
USD 1.19
(-0.83%)
USD 1.19
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -192.23 Million | -5.85 Million | -124.33 Million | -67.3 Million | -45.11 Million | -20.04 Million |
| Net Income | -246.41 Million | -221.1 Million | -165.16 Million | -81.35 Million | -43.13 Million | -22.71 Million |
| Depreciation & Amortization | 8.27 Million | 6.07 Million | 4.48 Million | 1.02 Million | 597 Thousand | 278 Thousand |
| Deferred income taxes | 992 Thousand | - | 781 Thousand | -23 Thousand | -306 Thousand | - |
| Stock-based compensation | 46.54 Million | 44.71 Million | 25.87 Million | 8.45 Million | 1.01 Million | 183 Thousand |
| Change in working capital | -6.69 Million | 155.17 Million | 6.44 Million | 2.04 Million | -5.02 Million | 2.17 Million |
| Other non-cash items | 5.06 Million | 9.29 Million | 3.24 Million | 2.55 Million | 1.73 Million | 27 Thousand |
| Investing Cash Flow | 68.35 Million | -225.64 Million | 14.81 Million | 57.71 Million | -203.23 Million | -788 Thousand |
| Investments in PPE | -12.38 Million | -10.2 Million | -13.24 Million | -17.5 Million | -2.33 Million | -788 Thousand |
| Acquisitions | 9.48 Million | 7.36 Million | -28.7 Million | -57.71 Million | 200.9 Million | - |
| Investment purchases | -365.03 Million | -540.02 Million | -129.34 Million | -208.56 Million | -208.9 Million | - |
| Sales/Maturities of investments | 445.77 Million | 324.58 Million | 157.41 Million | 283.77 Million | 8 Million | - |
| Other Investing Activities | -9.48 Million | -7.36 Million | 28.7 Million | 57.71 Million | -200.9 Million | - |
| Financing Cash Flow | 115.06 Million | 219.38 Million | 2.47 Million | 214.78 Million | 282.25 Million | 22.33 Million |
| Debt repayment | - | - | - | - | -15 Million | -5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1.55 Million | -1.73 Million | -324 Thousand | - |
| Common Stock Issuance | 115.06 Million | 217.98 Million | 4.03 Million | 216.18 Million | 265.03 Million | 17.33 Million |
| Other Financing Activities | 1.5 Million | 1.39 Million | 1.00 | 326 Thousand | 282.25 Million | 22.33 Million |
| Accounts receivables | - | - | - | 35 Thousand | - | - |
| Accounts payables | -992 Thousand | -3 Million | 652 Thousand | 2.19 Million | 1.96 Million | -61 Thousand |
| Inventory | - | - | - | -35 Thousand | - | - |
| Other working capital | -5.7 Million | 158.17 Million | 5.79 Million | -153 Thousand | -6.98 Million | 2.24 Million |
| Cash at beginning of period | 121.92 Million | 134.03 Million | 241.08 Million | 35.89 Million | 1.98 Million | 482 Thousand |
| Cash at end of period | 113.11 Million | 121.92 Million | 134.03 Million | 241.08 Million | 35.89 Million | 1.98 Million |
| Capital Expenditure | -12.38 Million | -10.2 Million | -13.24 Million | -17.5 Million | -2.33 Million | -788 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -8.8 Million | -12.11 Million | -107.04 Million | 205.18 Million | 33.9 Million | 1.5 Million |
| Free Cash Flow | -204.61 Million | -16.05 Million | -137.58 Million | -84.8 Million | -47.45 Million | -20.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -47.9 Million | -49.81 Million | -60.69 Million | -246.41 Million | -61.98 Million | -64.42 Million |
| Depreciation & Amortization | 2.27 Million | 2.17 Million | 2.18 Million | 8.27 Million | 2.25 Million | 2.17 Million |
| Deferred income taxes | - | - | -16.11 Million | 992 Thousand | -2.35 Million | -2.31 Million |
| Stock-based compensation | 8.42 Million | 7.92 Million | 9.23 Million | 46.54 Million | 11.95 Million | 14.3 Million |
| Change in working capital | -896 Thousand | -2.98 Million | -643 Thousand | -6.69 Million | 4.74 Million | -5.85 Million |
| Other non-cash items | 14.5 Million | 9.91 Million | 18.02 Million | 5.06 Million | 5.26 Million | 3 Million |
| Investing Cash Flow | 24.52 Million | 8.65 Million | -14.69 Million | 68.35 Million | 19.54 Million | -6.32 Million |
| Investments in PPE | -1.21 Million | -2.48 Million | -1.44 Million | -12.38 Million | -3.08 Million | -3.91 Million |
| Acquisitions | 32 Thousand | - | 13.24 Million | 9.48 Million | -22.63 Million | 2.41 Million |
| Investment purchases | -62.23 Million | -54.78 Million | -89.56 Million | -365.03 Million | -109.78 Million | -76.41 Million |
| Sales/Maturities of investments | 87.94 Million | 65.92 Million | 76.31 Million | 445.77 Million | 132.41 Million | 74 Million |
| Other Investing Activities | 25.73 Million | -1.13 Million | -13.24 Million | -9.48 Million | 22.63 Million | -2.41 Million |
| Financing Cash Flow | 615 Thousand | 152 Thousand | 402 Thousand | 115.06 Million | 44.63 Million | 69.95 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1000.00 | - | - | - | - | - |
| Common Stock Issuance | 648 Thousand | 191 Thousand | 402 Thousand | 115.06 Million | 44.61 Million | 69.95 Million |
| Other Financing Activities | -33 Thousand | -39 Thousand | 402 Thousand | 1.5 Million | 22 Thousand | 69.95 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -802 Thousand | 2.64 Million | -2.51 Million | -992 Thousand | 526 Thousand | -604 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -94 Thousand | -5.63 Million | 1.87 Million | -5.7 Million | 4.21 Million | -5.24 Million |
| Cash at beginning of period | 79.49 Million | 113.11 Million | 175.41 Million | 121.92 Million | 151.34 Million | 140.82 Million |
| Cash at end of period | 67.26 Million | 79.49 Million | 113.11 Million | 113.11 Million | 175.41 Million | 151.34 Million |
| Capital Expenditure | -1.21 Million | -2.48 Million | -1.44 Million | -12.38 Million | -3.08 Million | -3.91 Million |
| Effect of forex changes on cash | - | - | -764 Thousand | - | - | 764 Thousand |
| Net cash flow / Change in cash | -12.23 Million | -33.61 Million | -62.29 Million | -8.8 Million | 24.06 Million | 10.52 Million |
| Free Cash Flow | -38.58 Million | -44.9 Million | -49.45 Million | -204.61 Million | -43.2 Million | -57.01 Million |
OCT
SBP
3V64
PFBN
RAE
3139